Moderna, Inc. (MRNA)
47.61
+0.58
(+1.23%)
USD |
NASDAQ |
May 27, 16:00
47.80
+0.19
(+0.40%)
After-Hours: 19:49
Moderna Cash from Investing (Quarterly) : -76.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Gilead Sciences, Inc. | 1.77B |
| Arbutus Biopharma Corp. | 2.199M |
| Biogen, Inc. | -209.50M |
| AbbVie, Inc. | -574.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -630.00M |
| Cash from Financing (Quarterly) | 17.00M |
| Free Cash Flow | -1.603B |
| Free Cash Flow Per Share (Quarterly) | -1.752 |
| Free Cash Flow to Equity (Quarterly) | -685.00M |
| Free Cash Flow to Firm (Quarterly) | -674.89M |
| Free Cash Flow Yield | -8.61% |